American Portfolios Advisors’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
Other funds holding FLGT
American Portfolios Advisors's FLGT Position: Q3 2022 in Review
American Portfolios Advisors reduced its Fulgent Genetics (FLGT) stake by 2.9% in Q3 2022, selling an estimated $5.01K and leaving 3,335 shares worth $127K. The position accounts for 0.01% of the portfolio, ranked #1216.
American Portfolios Advisors first reported a position in FLGT in Q1 2020 and has held it in 11 quarters since. The position peaked at $358K in Q2 2021. 235 funds tracked by Wall St. Rank hold FLGT as of Q3 2022.
- American Portfolios Advisors held 3,335 shares of Fulgent Genetics worth $127K as of Q3 2022.
- American Portfolios Advisors sold 100 Fulgent Genetics shares in Q3 2022, an estimated $5.01K.
- Fulgent Genetics made up 0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #1216 holding.
- American Portfolios Advisors first reported a position in Fulgent Genetics in Q1 2020 and has held it in 11 quarters since.
- American Portfolios Advisors's Fulgent Genetics position peaked at $358K in Q2 2021.
- 235 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2022.
Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.